2 min read
Today, Veranex is proud to introduce Veranex Biopharma, a new sub-brand designed for biotech and pharmaceutical sponsors who need specialized support across the critical competencies that drive successful clinical development.
This launch highlights Veranex’s focused expertise, trusted by clinical development teams to deliver high-quality, submission-ready outcomes. It's a streamlined, purpose-built environment where sponsor teams can quickly assess fit, understand how we engage, and connect directly with the right experts.
Why we created Veranex Biopharma
The global biopharma development market reached $617B in 20241, with 70% of that market from outsourced products and services2.
Biotech and pharma organizations are moving faster and more efficiently than ever, often with leaner internal teams and increasing expectations for quality, consistency, and defensibility. Many clients don’t need a massive full-service model. They need trusted partners with specialized expertise who can integrate smoothly, deliver with rigor, and support key milestones.
We created Veranex Biopharma to make that partnership opportunity more visible and distinctive. It provides a clear, easier-to-find home for our specialized services that support clinical development and expose sponsors to other services in Veranex’s Innovation Contract Research Organization (iCRO) portfolio.
What services Veranex Biopharma brings into focus
Veranex Biopharma is designed around the areas sponsor teams most often need to scale, strengthen, or supplement. Our work supports:
- Evidence-focused services across biostatistics, biometrics, safety, clinical data management and documentation, helping teams maintain quality and defensibility from ongoing reporting through submission readiness.
- Drug Delivery systems solutions for biotech and pharma programs, capabilities that help teams design, develop, and validate delivery device systems with human factors engineering aligned to applicable real-world usability requirements.
- Commercial readiness and go-to-market support where it matters for adoption, helping teams clarify stakeholder needs and plan evidence and value communication that supports real-world uptake.
- Flexible models that align to how sponsor teams operate, including resourcing approaches that scale with program needs and timelines.
This site is thoughtfully built so clients can explore Veranex’s service areas, understand how we engage, identify the best starting point quickly, and contact us to begin a project.
What this means for clinical development teams
Veranex Biopharma is built to support how clinical development teams work. It’s milestone-driven, resource-aware, and focused on clarity and quality. With this dedicated experience, clients gain:
- A focused environment aligned to biopharma expectations
- Specialized teams that bring experience, discipline, consistency, and delivery confidence
- Engagement models that scale with your program and internal capacity
- A focus on quality and defensibility across the work products that matter most
- A partnership approach designed to integrate smoothly with sponsor workflows
Connected to Veranex and the Innovation CRO approach
Veranex is committed to scientific rigor, cross-functional collaboration, and practical execution. Our Innovation CRO approach brings the right expertise together to reduce friction, improve coordination, eliminate handoff delays, and help innovators’ programs advance efficiently from strategy to evidence to readiness.
Explore and learn at https://veranexbiopharma.com/
References:
1. Fortune Business Insights - "Biopharmaceuticals Market Size, Share, Forecast, [2034]"
2. McKinsey & Company - “Pulse check: Key trends shaping biopharma dealmaking in 2025”